Schedule 13G ownership disclosure

Eleven Biotherapeutics, Inc.

Security class unavailable · CUSIP: 286221106

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
653,877
Percent of class
3.6300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-15-000038
Form type
SC 13G/A
Filer
Carisma Therapeutics Inc.
CIK
CIK 1485003
Filed
Jan 21, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub